Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen to Help Canadian Gov't Develop Dxs for Livestock Pathogens, Agroterror

NEW YORK (GenomeWeb News) — Nanogen said today it has received an undisclosed amount of funding from several Canadian government agencies to help develop diagnostics that would detect natural or bioterror threats to livestock.
 
Under the agreement, Nanogen will use its NanoChip multiplexing microarray platform to develop diagnostics for diseases such as avian flu, foot-and-mouth disease, and other pathogens.
 
One of the funding agencies is the Canadian Food Inspection Agency, whose laboratory in Lethbridge, Alberta, will participate in the collaborative project. Also participating will be the National Center for Foreign Animal Diseases, located in Winnipeg, Manitoba.
 
Nanogen said the project, called “Adaptation of Recently Developed DNA Microarrays to NanoChip Microarray Technology for Detection of Agroterrorism Agents,” was approved by Defense Research and Development Canada under the Chemical, Biological, Radiological, and Nuclear Research and Technology Initiative.
 
Financial terms of the agreement were not disclosed.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.